Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.550
+0.110 (2.48%)
At close: Nov 3, 2026, 4:00 PM EST
4.580
+0.030 (0.66%)
Pre-market: Nov 4, 2026, 4:05 AM EST

Prime Medicine Revenue

Prime Medicine had revenue of $1.15M in the quarter ending June 30, 2026, with 3.50% growth. This brings the company's total for the last twelve months to $4.07M, down -17.90% year-over-year. In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth. That makes Prime Medicine the 40,621st largest company in the world by revenue and 5,424th in the United States.

Revenue (ttm)
$4.07M
Revenue Growth
-17.90%
P/S Ratio
198.74
Revenue / Employee
$27,897
Employees
146
Market Cap
809.46M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.63M1.65M55.28%
Dec 31, 20242.98M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ardelyx450.89M
Arbutus Biopharma181.72M
OmniAb40.21M
Aktis Oncology10.06M
Alumis7.40M
SL Science Holding3.27M
Revenue Rankings